Exploring halophilic environments as a source of new antibiotics

References

• Abed RMM, Dobrestov S, Al-Kharusi S, Schramm A, Jupp B, Golubic S. 2011. Cyanobacterial diversity and bioactivity of inland hypersaline microbial mats from a desert stream in the Sultanate of Oman. Fottea. 11(1):215–224.
   Web of Science ®Google Scholar
• Abed RMM, Dobretsov S, Al-Fori M, Gunasekera SP, Sudesh K, Paul VJ. 2013. Quorum-sensing inhibitory compounds from extremophilic microorganisms isolated from a hypersaline cyanobacterial mat. J Ind Microbiol Biotechnol. 40(7):759–772.
   PubMed Web of Science ®Google Scholar
• Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol. 215(3):403–410.
   PubMed Web of Science ®Google Scholar
• Amann RI, Ludwig W, Schleifer KH. 1995. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev. 59(1):143–169.
   PubMedGoogle Scholar
• Aminov RI. 2010. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol. 1:134.
   PubMed Web of Science ®Google Scholar
• Atanasova NS, Pietila MK, Oksanen HM. 2013. Diverse antimicrobial interactions of halophilic archaea and bacteria extend over geographical distances and cross the domain barrier. Microbiologyopen. 2(5):811–825.
   PubMed Web of Science ®Google Scholar
• Baati H, Guermazi S, Amdouni R, Gharsallah N, Sghir A, Ammar E. 2008. Prokaryotic diversity of a Tunisian multipond solar saltern. Extremophiles. 12(4):505–518.
   PubMed Web of Science ®Google Scholar
• Bakour S, Sankar SA, Rathored J, Biagini P, Raoult D, Fournier PE. 2016. Identification of virulence factors and antibiotic resistance markers using bacterial genomics. Future Microbiol. 11(3):455–466.
   PubMed Web of Science ®Google Scholar
• Ballav S, Kerkar S, Thomas S, Augustine N. 2015. Halophilic and halotolerant actinomycetes from a marine saltern of Goa, India producing anti-bacterial metabolites. J Biosci Bioeng. 119(3):323–330. [doi].
   PubMed Web of Science ®Google Scholar
• Baltz RH. 2007. Antimicrobials from Actinomycetes: back to the future. Microbe. 2:125–131.
   Google Scholar
• Basilio A, González I, Vicente MF, Gorrochategui J, Cabello A, González A, Genilloud O. 2003. Patterns of antimicrobial activities from soil actinomycetes isolated under different conditions of pH and salinity. J Appl Microbiol. 95(4):814–823.
   PubMed Web of Science ®Google Scholar
• Bentley SD, Chater KF, Cerdeño-Tárraga A-M, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, et al. 2002. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature. 417(6885):141–147.
   PubMed Web of Science ®Google Scholar
• Bérdy J. 2005. Bioactive microbial metabolites. J Antibiot. 58(1):1–26. .
   PubMed Web of Science ®Google Scholar
• Bérdy J. 2015. Microorganisms producing antibiotics. In: Sanchez S, Demain AL, editors. Antibiot Curr Innov Futur trends. Norfolk (UK): Caister Academic Press; p. 49–64.
   Google Scholar
• Bhargava N, Sharma P, Capalash N. 2010. Quorum sensing in Acinetobacter: an emerging pathogen. Crit Rev Microbiol. 36(4):349–360.
   PubMed Web of Science ®Google Scholar
• Blin K, Kim HU, Medema MH, Weber T. 2019. Recent development of antiSMASH and other computational approaches to mine secondary metabolite biosynthetic gene clusters. Brief Bioinform. 20(4):1103–1113.
   PubMed Web of Science ®Google Scholar
• Blin K, Pascal Andreu V, de Los Santos ELC, Del Carratore F, Lee SY, Medema MH, Weber T. 2019. The antiSMASH database version 2: a comprehensive resource on secondary metabolite biosynthetic gene clusters. Nucleic Acids Res. 47(D1):D625–D630.
   PubMed Web of Science ®Google Scholar
• Blum P. 2008. Archaea: new models for prokaryotic biology. Norwich: Horizon Scientific Press.
   Google Scholar
• Boubetra D, Sabaou N, Zitouni A, Bijani C, Lebrihi A, Mathieu F. 2013. Taxonomy and chemical characterization of new antibiotics produced by Saccharothrix SA198 isolated from a Saharan soil. Microbiol Res. 168(4):223–230.
   PubMedGoogle Scholar
• Brady SF, Chao CJ, Handelsman J, Clardy J. 2001. Cloning and heterologous expression of a natural product biosynthetic gene cluster from eDNA. Org Lett. 3(13):1981–1984.
   PubMed Web of Science ®Google Scholar
• Brown ED. 2013. Is the GAIN Act a turning point in new antibiotic discovery? Can J Microbiol. 59(3):153–156.
   PubMed Web of Science ®Google Scholar
• Brown ED, Wright GD. 2016. Antibacterial drug discovery in the resistance era. Nature. 529(7586):336–343.
   PubMed Web of Science ®Google Scholar
• Buchanan GO, Williams PG, Feling RH, Kauffman CA, Jensen PR, Fenical W. 2005. Sporolides A and B: structurally unprecedented halogenated macrolides from the marine actinomycete Salinispora tropica. Org Lett. 7(13):2731–2734.
   PubMed Web of Science ®Google Scholar
• Buchfink B, Xie C, Huson DH. 2015. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 12(1):59–60.
   PubMed Web of Science ®Google Scholar
• Bud R. 2007. Antibiotics: the epitome of a wonder drug. BMJ. 334(Suppl 1):s6–s6.
   PubMedGoogle Scholar
• Bull AT. 2011. Actinobacteria of the extremobiosphere. In: Horikoshi K, editor. Extremophiles handbook. Tokyo: Springer; p. 1203–1240.
   Google Scholar
• Bull AT, Asenjo JA. 2013. Microbiology of hyper-arid environments: recent insights from the Atacama Desert, Chile. Antonie Van Leeuwenhoek. 103(6):1173–1179.
   PubMed Web of Science ®Google Scholar
• Bull AT, Ward AC, Goodfellow M. 2000. Search and discovery strategies for biotechnology: the paradigm shift. Microbiol Mol Biol Rev. 64(3):573–606.
   PubMed Web of Science ®Google Scholar
• Busarakam K, Bull AT, Girard G, Labeda DP, Van Wezel GP, Goodfellow M. 2014. Streptomyces leeuwenhoekii sp. nov., the producer of chaxalactins and chaxamycins, forms a distinct branch in Streptomyces gene trees. Antonie Van Leeuwenhoek. 105(5):849–861.
   PubMed Web of Science ®Google Scholar
• Busetti A, Shaw G, Megaw J, Gorman SP, Maggs CA, Gilmore BF. 2014. Marine-derived quorum-sensing inhibitory activities enhance the antibacterial efficacy of tobramycin against Pseudomonas aeruginosa. Mar Drugs. 13(1):1–28.
   PubMed Web of Science ®Google Scholar
• Bussi C, Gutierrez MG. 2019. Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules. FEMS Microbiol Rev. 43(4):341–361.
   PubMed Web of Science ®Google Scholar
• Butler MS, Blaskovich MA, Cooper MA. 2017. Antibiotics in the clinical pipeline at the end of 2015. J Antibiot. 70(1):3–24.
   PubMed Web of Science ®Google Scholar
• Challis GL. 2008. Mining microbial genomes for new natural products and biosynthetic pathways. Microbiology. 154(Pt 6):1555–1569.
   PubMedGoogle Scholar
• Challis GL, Ravel J. 2000. Coelichelin, a new peptide siderophore encoded by the Streptomyces coelicolor genome: structure prediction from the sequence of its non-ribosomal peptide synthetase. FEMS Microbiol Lett. 187(2):111–114.
   PubMed Web of Science ®Google Scholar
• Charan RD, Schlingmann G, Janso J, Bernan V, Feng X, Carter GT. 2004. Diazepinomicin, a new antimicrobial alkaloid from a marine Micromonospora sp. J Nat Prod. 67(8):1431–1433.
   PubMed Web of Science ®Google Scholar
• Charlop-Powers Z, Pregitzer CC, Lemetre C, Ternei MA, Maniko J, Hover BM, Calle PY, McGuire KL, Garbarino J, Forgione HM, et al. 2016. Urban park soil microbiomes are a rich reservoir of natural product biosynthetic diversity. Proc Natl Acad Sci U S A. 113(51):14811–14816.
   PubMed Web of Science ®Google Scholar
• Chen D, Feng J, Huang L, Zhang Q, Wu J, Zhu X, Duan Y, Xu Z. 2014. Identification and characterization of a new erythromycin biosynthetic gene cluster in Actinopolyspora erythraea YIM90600, a novel erythronolide-producing halophilic actinomycete isolated from salt field. PLOS One. 9(9):e108129.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang G, Bu T, Zhang Y, Wang Y, Liu M, Lin X. 2010. Phylogenetic analysis and screening of antimicrobial and cytotoxic activities of moderately halophilic bacteria isolated from the Weihai Solar Saltern (China). World J Microbiol Biotechnol. 26(5):879–888.
   Web of Science ®Google Scholar
• Chen Y-G, Cui X-L, Pukall R, Li H-M, Yang Y-L, Xu L-H, Wen M-L, Peng Q, Jiang C-L. 2007. Salinicoccus kunmingensis sp. nov., a moderately halophilic bacterium isolated from a salt mine in Yunnan, south-west China. Int J Syst Evol Microbiol. 57(Pt 10):2327–2332.
   PubMedGoogle Scholar
• Cheung J, Danna KJ, O'Connor EM, Price LB, Shand RF. 1997. Isolation, sequence, and expression of the gene encoding halocin H4, a bacteriocin from the halophilic archaeon Haloferax mediterranei R4. J Bacteriol. 179(2):548–551.
   PubMed Web of Science ®Google Scholar
• Chiang Y-M, Szewczyk E, Nayak T, Davidson AD, Sanchez JF, Lo H-C, Ho W-Y, Simityan H, Kuo E, Praseuth A, et al. 2008. Molecular genetic mining of the Aspergillus secondary metabolome: discovery of the emericellamide biosynthetic pathway. Chem Biol. 15(6):527–532.
   PubMedGoogle Scholar
• Choi H, Mascuch SJ, Villa FA, Byrum T, Teasdale ME, Smith JE, Preskitt LB, Rowley DC, Gerwick L, Gerwick WH, et al. 2012. Honaucins A-C, potent inhibitors of inflammation and bacterial quorum sensing: synthetic derivatives and structure-activity relationships. Chem Biol. 19(5):589–598.
   PubMedGoogle Scholar
• Ciofu O, Giwercman B, Høiby N, Pedersen SS. 1994. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. APMIS. 102(9):674–680.
   PubMed Web of Science ®Google Scholar
• Clardy J, Fischbach MA, Walsh CT. 2006. New antibiotics from bacterial natural products. Nat Biotechnol. 24(12):1541–1550.
   PubMed Web of Science ®Google Scholar
• Clark BR, Engene N, Teasdale ME, Rowley DC, Matainaho T, Valeriote FA, Gerwick WH. 2008. Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum. J Nat Prod. 71(9):1530–1537.
   PubMed Web of Science ®Google Scholar
• Clatworthy AE, Pierson E, Hung DT. 2007. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol. 3(9):541–548.
   PubMed Web of Science ®Google Scholar
• Coates ARM, Hu Y. 2007. Novel approaches to developing new antibiotics for bacterial infections. Br. J. Pharmacol. 152(8):1147–1154.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Newman DJ. 2013. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 1830(6):3670–3695.
   PubMed Web of Science ®Google Scholar
• Culp EJ, Waglechner N, Wang W, Fiebig-Comyn AA, Hsu Y-P, Koteva K, Sychantha D, Coombes BK, Van Nieuwenhze MS, Brun YV, et al. 2020. Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling. Nature. 578(7796):582–587.
   PubMed Web of Science ®Google Scholar
• Czaran TL, Hoekstra RF, Pagie L. 2002. Chemical warfare between microbes promotes biodiversity. Proc Natl Acad Sci U S A. 99(2):786–790.
   PubMed Web of Science ®Google Scholar
• Dall C. 2019. Achaogen bankruptcy raises worry over antibiotic pipeline. CIDRAP News. [cited 2020 Feb 7]. http://www.cidrap.umn.edu/news-perspective/2019/04/achaogen-bankruptcy-raises-worry-over-antibiotic-pipeline
   Google Scholar
• Davies J. 2006. Where have all the antibiotics gone? Can J Infect Dis Med Microbiol. 17(5):287–290.
   PubMedGoogle Scholar
• Dávila-Céspedes A, Hufendiek P, Crüsemann M, Schäberle TF, König GM. 2016. Marine-derived myxobacteria of the suborder Nannocystineae: an underexplored source of structurally intriguing and biologically active metabolites. Beilstein J Org Chem. 12:969–984.
   PubMed Web of Science ®Google Scholar
• Demain AL. 2014. Importance of microbial natural products and the need to revitalize their discovery. J Ind Microbiol Biotechnol. 41(2):185–201.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran D, Rajakumar G, Sivamani P, Selvamani S, Panneerselvam A. 2004. Screening of salt pans actinomycetes for antibacterial agents. Internet J Microbiol. 1:2–5.
   Google Scholar
• Dietera A, Hamm A, Fiedler H-P, Goodfellow M, Müller WEG, Brun R, Beil W, Bringmann G. 2003. Pyrocoll, an antibiotic, antiparasitic and antitumor compound produced by a novel alkaliphilic Streptomyces strain. J Antibiot (Tokyo). 56(7):639–646.
   PubMed Web of Science ®Google Scholar
• Dobretsov S, Teplitski M, Alagely A, Gunasekera SP, Paul VJ. 2010. Malyngolide from the cyanobacterium Lyngbya majuscula interferes with quorum sensing circuitry. Environ Microbiol Rep. 2(6):739–744.
   PubMed Web of Science ®Google Scholar
• Fischbach MA, Walsh CT. 2006. Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem Rev. 106(8):3468–3496.
   PubMed Web of Science ®Google Scholar
• Fischbach MA, Walsh CT. 2009. Antibiotics for emerging pathogens. Science. 325(5944):1089–1093.
   PubMed Web of Science ®Google Scholar
• Fleming A. 1929. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol. 10(3):226–236.
   Google Scholar
• Friedman D, Alper J. 2014. Challenges in overcoming antibiotic resistance. In: Technological challenges in antibiotic discovery and development. Washington: National Academies Press; p. 7–18. [cited 2020 Feb 7]. www.nap.edu.
   Google Scholar
• Gajardo GM, Beardmore JA. 2012. The brine shrimp Artemia: adapted to critical life conditions. Front Physiol. 3:185.
   PubMed Web of Science ®Google Scholar
• Ghanmi F, Carré-Mlouka A, Vandervennet M, Boujelben I, Frikha D, Ayadi H, Peduzzi J, Rebuffat S, Maalej S. 2016. Antagonistic interactions and production of halocin antimicrobial peptides among extremely halophilic prokaryotes isolated from the solar saltern of Sfax, Tunisia. Extremophiles. 20(3):363–374.
   PubMed Web of Science ®Google Scholar
• Gohel SD, Sharma AK, Dangar KG, Thakrar FJ, Singh SP. 2015. Antimicrobial and biocatalytic potential of haloalkaliphilic actinobacteria. In: Halophiles. Cham: Springer; p. 29–55.
   Google Scholar
• Gómez-Silva B, Rainey FA, Warren-Rhodes KA, McKay CP, Navarro-González R. 2008. Atacama desert soil microbiology. In: Dion P, editor. Nautiyal CS microbiology of extreme soils. Berlin Heidelberg: Springer; p. 117–132.
   Google Scholar
• Gottlieb D. 1973. General consideration and implications of the Actinomycetales. Symp Ser Soc Appl Bacteriol. 2:1–10.
   PubMedGoogle Scholar
• Gross H. 2007. Strategies to unravel the function of orphan biosynthesis pathways: recent examples and future prospects. Appl Microbiol Biotechnol. 75(2):267–277.
   PubMed Web of Science ®Google Scholar
• Guan T-W, Wu N, Xia Z-F, Ruan J-S, Zhang X-P, Huang Y, Zhang L-L. 2011. Saccharopolyspora lacisalsi sp. nov., a novel halophilic actinomycete isolated from a salt lake in Xinjiang, China. Extremophiles. 15(3):373–378.
   PubMed Web of Science ®Google Scholar
• Gunde-Cimerman N, Ramos J, Plemenitaš A. 2009. Halotolerant and halophilic fungi. Mycol Res. 113(Pt 11):1231–1241.
   PubMedGoogle Scholar
• Gunde-Cimerman N, Zalar P. 2014. Extremely halotolerant and halophilic fungi inhabit brine in solar salterns around the globe. Food Technol Biotechnol. 52:170–179.
   Web of Science ®Google Scholar
• Gunde-Cimermana N, Zalarb P, de Hoogc S, Plemenitasd A. 2000. Hypersaline waters in salterns – natural ecological niches for halophilic black yeasts. FEMS Microbiol Ecol. 32(3):235–240.
   PubMed Web of Science ®Google Scholar
• Hamaki T, Suzuki M, Fudou R, Jojima Y, Kajiura T, Tabuchi A, Sen K, Shibai H. 2005. Isolation of novel bacteria and actinomycetes using soil-extract agar medium. J Biosci Bioeng. 99(5):485–492.
   PubMed Web of Science ®Google Scholar
• Hamedi J, Mohammadipanah F, Ventosa A. 2013. Systematic and biotechnological aspects of halophilic and halotolerant actinomycetes. Extremophiles. 17(1):1–13.
   PubMed Web of Science ®Google Scholar
• Hamm JN, Erdmann S, Eloe-Fadrosh EA, Angeloni A, Zhong L, Brownlee C, Williams TJ, Barton K, Carswell S, Smith MA, et al. 2019. Unexpected host dependency of Antarctic nanohaloarchaeota. Proc Natl Acad Sci U S A. 116(29):14661–14670.
   PubMed Web of Science ®Google Scholar
• Haseltine C, Hill T, Montalvo-Rodriguez R, Kemper SK, Shand RF, Blum P. 2001. Secreted euryarchaeal microhalocins kill hyperthermophilic crenarchaea. J Bacteriol. 183(1):287–291.
   PubMed Web of Science ®Google Scholar
• Herbert RA. 1992. A perspective on the biotechnological potential of extremophiles. Trends Biotechnol. 10(11):395–402.
   PubMed Web of Science ®Google Scholar
• Hong K-W, Koh C-L, Sam C-K, Yin W-F, Chan K-G. 2012. Quorum quenching revisited—from signal decays to signalling confusion. Sensors. 12(4):4661–4696.
   PubMed Web of Science ®Google Scholar
• Hug JJ, Bader CD, Remškar M, Cirnski K, Müller R. 2018. Concepts and methods to access novel antibiotics from actinomycetes. Antibiotics. 7(2):44.
   Google Scholar
• Imachi H, Nobu MK, Nakahara N, Morono Y, Ogawara M, Takaki Y, Takano Y, Uematsu K, Ikuta T, Ito M, et al. 2020. Isolation of an archaeon at the prokaryote-eukaryote interface. Nature. 577(7791):519–525.
   PubMed Web of Science ®Google Scholar
• Imada C, Koseki N, Kamata M, Kobayashi T, Hamada-Sato N. 2007. Isolation and characterization of antibacterial substances produced by marine actinomycetes in the presence of seawater. Actinomycetologica. 21(1):27–31.
   Google Scholar
• Imai Y, Meyer KJ, Iinishi A, Favre-Godal Q, Green R, Manuse S, Caboni M, Mori M, Niles S, Ghiglieri M, et al. 2019. A new antibiotic selectively kills gram-negative pathogens. Nature. 576(7787):459–464.
   PubMed Web of Science ®Google Scholar
• Indah H, Putri F, Utama GL. 2015. Preliminary studies of halophilic yeasts antimicrobial activities isolated from cocoa bean pulp towards E. coli and Salmonella spp. Int J Adv Sci Eng Inf Technol. 5(2):107–109.
   Google Scholar
• Irshad A, Ahmad I, Kim SB. 2013. Isolation, characterization and antimicrobial activity of halophilic bacteria in foreshore soils. African J Microbiol Res. 7:164–173.
   Google Scholar
• Irshad A, Kim SB, Ahmad I. 2014. Culturable diversity of halophilic bacteria in foreshore soils. Braz J Microbiol. 45(2):563–571.
   PubMed Web of Science ®Google Scholar
• Jang KH, Nam S-J, Locke JB, Kauffman CA, Beatty DS, Paul LA, Fenical W. 2013. Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete. Angew Chem Int Ed Engl. 52(30):7822–7824.
   PubMed Web of Science ®Google Scholar
• Jensen PR, Dwight R, Fenical W. 1991. Distribution of actinomycetes in near-shore tropical marine sediments. Appl Environ Microbiol. 57(4):1102–1108.
   PubMed Web of Science ®Google Scholar
• Jose PA, Jebakumar SR. 2014. Unexplored hypersaline habitats are sources of novel actinomycetes. Front Microbiol. 5:242.
   PubMed Web of Science ®Google Scholar
• Jose PA, Jebakumar SRD. 2013. Diverse actinomycetes from Indian coastal solar salterns-a resource for antimicrobial screening. J.Pure Appl.Microbiol. 7:2569–2575.
   Web of Science ®Google Scholar
• Jose PA, Santhi VS, Jebakumar SR. 2011. Phylogenetic-affiliation, antimicrobial potential and PKS gene sequence analysis of moderately halophilic Streptomyces sp. inhabiting an Indian saltpan. J Basic Microbiol. 51(4):348–356.
   PubMed Web of Science ®Google Scholar
• Kaeberlein T, Lewis K, Epstein SS. 2002. Isolating “uncultivable” microorganisms in pure culture in a simulated natural environment. Science. 296(5570):1127–1129.
   PubMed Web of Science ®Google Scholar
• Kamat TK, Kiran S, Kerkar S. 2011. Antimicrobial potential of Bacillus marismortal, a salt pan isolate of Cavellosim, Goa-India. Int J Adv Biotechnol Res. 2:321–328.
   Google Scholar
• Kavitha A, Prabhakar P, Vijayalakshmi M, Venkateswarlu Y. 2010. Purification and biological evaluation of the metabolites produced by Streptomyces sp. TK-VL_333. Res Microbiol. 161(5):335–345.
   PubMed Web of Science ®Google Scholar
• Kavitha P, Lipton AP, Sarika AR, Aishwarya MS. 2011. Growth characteristics and halocin production by a new isolate, Haloferax volcanii KPS1 from Kovalam solar saltern (India). Res J Biol Sci. 6:257–262.
   Google Scholar
• Kessel M, Klink F. 1980. Archaebacterial elongation factor is ADP-ribosylated by diphtheria toxin. Nature. 287(5779):250–251.
   PubMed Web of Science ®Google Scholar
• Khelaifia S, Drancourt M. 2012. Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology. Clin Microbiol Infect. 18(9):841–848. .
   PubMed Web of Science ®Google Scholar
• Koch C, Høiby N. 2000. Diagnosis and treatment of cystic fibrosis. Respiration. 67(3):239–247.
   PubMed Web of Science ®Google Scholar
• Koehn FE, Carter GT. 2005. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 4(3):206–220.
   PubMed Web of Science ®Google Scholar
• Kokare CR, Mahadik KR, Kadam SS, Chopade BA. 2004. Isolation, characterization and antimicrobial activity of marine halophilic Actinopolyspora species AH1 from the west coast of India. Curr Sci. 86:593–597.
   Web of Science ®Google Scholar
• Kovac J, Sneader W. 2006. Chemical education today book & media reviews drug discovery: a history. J Chem Educ. 83(8):1139.
   Google Scholar
• Kumar V, Tiwari SK. 2017a. Activity-guided separation and characterization of new halocin HA3 from fermented broth of Haloferax larsenii HA3. Extremophiles. 21(3):609–621.
   PubMed Web of Science ®Google Scholar
• Kumar V, Tiwari SK. 2017b. Halocin HA1: an archaeocin produced by the haloarchaeon Haloferax larsenii HA1. Process Biochem. 61:202–208.
   Web of Science ®Google Scholar
• Lam KS. 2006. Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol. 9(3):245–251.
   PubMed Web of Science ®Google Scholar
• León MJ, Fernández AB, Ghai R, Sánchez-Porro C, Rodriguez-Valera F, Ventosa A. 2014. From metagenomics to pure culture: isolation and characterization of the moderately halophilic bacterium Spiribacter salinus gen. nov., sp. nov. Appl Environ Microbiol. 80(13):3850–3857.
   PubMed Web of Science ®Google Scholar
• Lequerica JL, O'Connor JE, Such L, Alberola A, Meseguer I, Dolz M, Torreblanca M, Moya A, Colom F, Soria B, et al. 2006. A halocin acting on Na+/H + exchanger of haloarchaea as a new type of inhibitor in NHE of mammals. J Physiol Biochem. 62(4):253–262.
   PubMed Web of Science ®Google Scholar
• Levy S. 2001. Thanks to Penicillin…He Will Come Home, The Antibiotic Paradox. New York: The National WWII Museum.
   Google Scholar
• Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 5(1):48–56.
   PubMed Web of Science ®Google Scholar
• Lewis K. 2012. Antibiotics: recover the lost art of drug discovery. Nature. 485(7399):439–440.
   PubMed Web of Science ®Google Scholar
• Lewis K. 2013. Platforms for antibiotic discovery. Nat Rev Drug Discov. 12(5):371–387.
   PubMed Web of Science ®Google Scholar
• Li B, Walsh CT. 2010. Identification of the gene cluster for the dithiolopyrrolone antibiotic holomycin in Streptomyces clavuligerus. Proc Natl Acad Sci U S A. 107(46):19731–19735.
   PubMed Web of Science ®Google Scholar
• Li F, Maskey RP, Qin S, Sattler I, Fiebig HH, Maier A, Zeeck A, Laatsch H. 2005. Chinikomycins A and B: isolation, structure elucidation, and biological activity of novel antibiotics from a marine Streptomyces sp. isolate M045#, 1. J Nat Prod. 68(3):349–353.
   PubMed Web of Science ®Google Scholar
• Li X, Dobretsov S, Xu Y, Xiao X, Hung O, Qian PY. 2006. Antifouling diketopiperazines produced by a deep-sea bacterium, Streptomyces fungicidicus. Biofouling. 22(3):187–194.
   PubMed Web of Science ®Google Scholar
• Li X, Yu YH. 2015. Biodiversity and screening of halophilic bacteria with hydrolytic and antimicrobial activities from Yuncheng Salt Lake, China. Biologia. 70(2):151–156.
   Web of Science ®Google Scholar
• Li Y, Xiang H, Liu J, Zhou M, Tan H. 2003. Purification and biological characterization of halocin C8, a novel peptide antibiotic from Halobacterium strain AS7092. Extremophiles. 7(5):401–407.
   PubMed Web of Science ®Google Scholar
• Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, Mueller A, Schäberle TF, Hughes DE, Epstein S, et al. 2015. A new antibiotic kills pathogens without detectable resistance. Nature. 517(7535):455–459.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 23(1–3):3–25.
   Web of Science ®Google Scholar
• Lok C. 2015. Mining the microbial dark matter. Nature. 522(7556):270–273.
   PubMed Web of Science ®Google Scholar
• Maheshwari DK, Saraf M. 2015. Halophiles: biodiversity and sustainable exploitation. Switzerland: Springer.
   Google Scholar
• Mahyudin NA, Blunt JW, Cole AL, Munro MH. 2012. The isolation of a new S-methyl benzothioate compound from a marine-derived Streptomyces sp. J Biomed Biotechnol. 2012:894708.
   PubMedGoogle Scholar
• Manam RR, Teisan S, White DJ, Nicholson B, Grodberg J, Neuteboom STC, Lam KS, Mosca DA, Lloyd GK, Potts BCM, et al. 2005. Lajollamycin, a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic from the marine actinomycete Streptomyces nodosus. J Nat Prod. 68(2):240–243.
   PubMed Web of Science ®Google Scholar
• Martins MB, Carvalho I. 2007. Diketopiperazines: biological activity and synthesis. Tetrahedron. 63(40):9923–9932.
   Web of Science ®Google Scholar
• Maskey RP, Helmke E, Laatsch H. 2003. Himalomycin A and B: isolation and structure elucidation of new fridamycin type antibiotics from a marine Streptomyces isolate. J Antibiot. 56(11):942–949.
   PubMed Web of Science ®Google Scholar
• Maskey RP, Li F, Qin S, Fiebig HH, Laatsch H. 2003. Chandrananimycins A approximately C: production of novel anticancer antibiotics from a marine Actinomadura sp. isolate M048 by variation of medium composition and growth conditions. J Antibiot. 56(7):622–629.
   PubMed Web of Science ®Google Scholar
• Maskey RP, Sevvana M, Usón I, Helmke E, Laatsch H. 2004. Gutingimycin: a highly complex metabolite from a marine streptomycete. Angew Chem Int Ed Engl. 43(10):1281–1283.
   PubMed Web of Science ®Google Scholar
• Mazguene S, Rossi M, Gogliettino M, Palmieri G, Cocca E, Mirino S, Imadalou-Idres N, Benallaoua S. 2018. Isolation and characterization from solar salterns of North Algeria of a haloarchaeon producing a new halocin. Extremophiles. 22(2):259–270.
   PubMed Web of Science ®Google Scholar
• McGuire JM, Bunch RL, Anderson RC, Boaz HE, Flynn EH, Powell HM, et al. 1952. Ilotycin, a new antibiotic. Antibiot Chemother. 2:281–283.
   Google Scholar
• Meklat A, Sabaou N, Zitouni A, Mathieu F, Lebrihi A. 2011. Isolation, taxonomy, and antagonistic properties of halophilic actinomycetes in Saharan soils of Algeria. Appl Environ Microbiol. 77(18):6710–6714.
   PubMed Web of Science ®Google Scholar
• Meknaci R, Lopes P, Servy C, Le Caer J-P, Andrieu J-P, Hacène H, Ouazzani J. 2014. Agar-supported cultivation of Halorubrum sp. SSR, and production of halocin C8 on the scale-up prototype Platotex. Extremophiles. 18(6):1049–1055.
   PubMed Web of Science ®Google Scholar
• Meseguer I, Rodriguez-Valera F. 1985. Production and purification of halocin H4. FEMS Microbiol. Lett. 28(2):177–182.
   Web of Science ®Google Scholar
• Meseguer I, Rodriguez-Valera F. 1986. Effect of halocin H4 on cells of Halobacterium halobium. J Gen Microbiol. 132(11):3061–3068.
   Google Scholar
• Meseguer I, Torreblanca M, Konishi T. 1995. Specific inhibition of the halobacterial Na+/H + antiporter by halocin H6. J Biol Chem. 270(12):6450–6455.
   PubMed Web of Science ®Google Scholar
• Mohammadipanah F, Wink J. 2016. Actinobacteria from arid and desert habitats: diversity and biological activity. Front Microbiol. 6:1541.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 75(3):311–335.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 79(3):629–661.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM, Snader KM. 2003. Natural products as sources of new drugs over the period 1981–2002. J Nat Prod. 66(7):1022–1037. [doi].
   PubMed Web of Science ®Google Scholar
• NIH. 2003. Research on microbial biofilms: PA-03-047. J Investig Med. 51:162–163.
   Google Scholar
• Nikolouli K, Mossialos D. 2012. Bioactive compounds synthesized by non-ribosomal peptide synthetases and type-I polyketide synthases discovered through genome-mining and metagenomics. Biotechnol Lett. 34(8):1393–1403.
   PubMed Web of Science ®Google Scholar
• O’Connor E. 2002. Purification and characterization of microhalocin R1 from Halobacterium salinarum GN101 [Dosctoral dissertation]. Flagstaff (AZ): Northern Arizona University.
   Google Scholar
• O’Connor EM, Shand RF. 2002. Halocins and sulfolobicins: the emerging story of archaeal protein and peptide antibiotics. J Ind Microbiol Biotech. 28(1):23–31.
   PubMed Web of Science ®Google Scholar
• Oh DC, Williams PG, Kauffman CA, Jensen PR, Fenical W. 2006. Cyanosporasides A and B, chloro- and cyano-cyclopenta[a]indene glycosides from the marine actinomycete “Salinispora pacifica”. Org Lett. 8(6):1021–1024.
   PubMed Web of Science ®Google Scholar
• Ohta S, Ono F, Shiomi Y, Nakao T, Aozasa O, Nagate T, Kitamura K, Yamaguchi S, Nishi M, Miyata H. 1998. Anti-herpes simplex virus substances produced by the marine green alga, Dunaliella primolecta. J Appl Phycol. 10(4):349–356.
   Web of Science ®Google Scholar
• Okami Y, Okazaki T, Kitahara T, Umezawa H. 1976. Studies on marine microorganisms. V. A new antibiotic, aplasmomycin, produced by a streptomycete isolated from shallow sea mud. J Antibiot. 29(10):1019–1025.
   PubMed Web of Science ®Google Scholar
• Okoro CK, Brown R, Jones AL, Andrews BA, Asenjo JA, Goodfellow M, Bull AT. 2009. Diversity of culturable actinomycetes in hyper-arid soils of the Atacama Desert, Chile. Antonie Van Leeuwenhoek. 95(2):121–133.
   PubMed Web of Science ®Google Scholar
• Oren A. 2002. Diversity of halophilic microorganisms: environments, phylogeny, physiology, and applications. J Ind Microbiol Biotechnol. 28(1):56–63.
   PubMed Web of Science ®Google Scholar
• Oren A. 2006. Adaptation of halophilic archaea to life at high salt concentrations. In: Läuchli A, Lüttge U, editors. Salinity: environment – plants – molecules. Dordrecht: Kluwer Academic Publishers; p. 81–96.
   Google Scholar
• Oren A. 2008. Microbial life at high salt concentrations: phylogenetic and metabolic diversity. Saline Syst. 4:2.
   PubMedGoogle Scholar
• Owens B. 2017. Solithromycin rejection chills antibiotic sector. Nat Biotechnol. 35(3):187–188.
   PubMed Web of Science ®Google Scholar
• Papagianni M. 2012. Recent advances in engineering the central carbon metabolism of industrially important bacteria. Microb Cell Fact. 11:50.
   PubMed Web of Science ®Google Scholar
• Pašić L, Velikonja BH, Ulrih NP. 2008. Optimization of the culture conditions for the production of a bacteriocin from halophilic archaeon Sech7a. Prep Biochem Biotechnol. 38(3):229–245.
   PubMed Web of Science ®Google Scholar
• Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. 2007. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov. 6(1):29–40.
   PubMed Web of Science ®Google Scholar
• Pettit RK. 2011. Culturability and secondary metabolite diversity of extreme microbes: expanding contribution of deep sea and deep-sea vent microbes to natural product discovery. Mar Biotechnol. 13(1):1–11.
   PubMed Web of Science ®Google Scholar
• Pinchuk IV, Bressollier P, Sorokulova IB, Verneuil B, Urdaci MC. 2002. Amicoumacin antibiotic production and genetic diversity of Bacillus subtilis strains isolated from different habitats. Res Microbiol. 153(5):269–276.
   PubMed Web of Science ®Google Scholar
• Platas G, Meseguer I, Amils R. 1996. Optimization of the production of a bacteriocin from Haloferax mediterranei Xia3. Microbiologia. 12(1):75–84.
   PubMedGoogle Scholar
• Plemenitaš A, Lenassi M, Konte T, Kejžar A, Zajc J, Gostinčar C, Gunde-Cimerman N. 2014. Adaptation to high salt concentrations in halotolerant/halophilic fungi: a molecular perspective. Front Microbiol. 5:199.
   PubMed Web of Science ®Google Scholar
• Plemenitaš A, Vaupotič T, Lenassi M, Kogej T, Gunde-Cimerman N. 2008. Adaptation of extremely halotolerant black yeast Hortaea werneckii to increased osmolarity: a molecular perspective at a glance. Stud Mycol. 61:67–75.
   PubMed Web of Science ®Google Scholar
• Potera C. 1999. Forging a link between biofilms and disease. Science. 283(5409):1837–1839.
   PubMed Web of Science ®Google Scholar
• Pramanik A, Sundararaman M, Das S, Ghosh U, Mukherjee J. 2011. Isolation and characterization of cyanobacteria possessing antimicrobial activity from the Sundarbans, the World’s largest tidal mangrove forest. J Phycol. 47(4):731–743.
   PubMed Web of Science ®Google Scholar
• Prangishvili D, Holz I, Stieger E, Nickell S, Kristjansson JK, Zillig W. 2000. Sulfolobicins, specific proteinaceous toxins produced by strains of the extremely thermophilic archaeal genus Sulfolobus. J Bacteriol. 182(10):2985–2988.
   PubMed Web of Science ®Google Scholar
• Price LB, Shand RF. 2000. Halocin S8: a 36-amino-acid microhalocin from the haloarchaeal strain S8a. J Bacteriol. 182(17):4951–4958.
   PubMed Web of Science ®Google Scholar
• Projan SJ. 2003. Why is big pharma getting out of antibacterial drug discovery? Curr Opin Microbiol. 6(5):427–430.
   PubMed Web of Science ®Google Scholar
• Projan SJ, Shlaes DM. 2004. Antibacterial drug discovery: is it all downhill from here? Clin Microbiol Infect. 10(Suppl 4):18–22.
   PubMedGoogle Scholar
• Qi SH, Xu Y, Gao J, Qian PY, Zhang S. 2009. Antibacterial and antilarval compounds from marine bacterium Pseudomonas rhizosphaerae. Ann Microbiol. 59(2):229–233.
   Web of Science ®Google Scholar
• Quadri I, Hassani II, l‘Haridon S, Chalopin M, Hacène H, Jebbar M. 2016. Characterization and antimicrobial potential of extremely halophilic archaea isolated from hypersaline environments of the Algerian Sahara. Microbiol Res. 186-187:119–131.
   PubMed Web of Science ®Google Scholar
• Raju TN. 2000. The Nobel chronicles. 1988: James Whyte Black, (b 1924), Gertrude Elion (1918–99), and George H Hitchings (1905–98). Lancet. 355(9208):1022.
   PubMedGoogle Scholar
• Rateb ME, Houssen WE, Arnold M, Abdelrahman MH, Deng H, Harrison WTA, Okoro CK, Asenjo JA, Andrews BA, Ferguson G, et al. 2011. Chaxamycins A–D, bioactive ansamycins from a hyper-arid desert Streptomyces sp. J Nat Prod. 74(6):1491–1499.
   PubMed Web of Science ®Google Scholar
• Rateb ME, Houssen WE, Harrison WTA, Deng H, Okoro CK, Asenjo JA, Andrews BA, Bull AT, Goodfellow M, Ebel R, et al. 2011. Diverse metabolic profiles of a Streptomyces strain isolated from a hyper-arid environment. J Nat Prod. 74(9):1965–1971.
   PubMed Web of Science ®Google Scholar
• Rdest U, Sturm M. 1987. Bacteriocins from halobacteria. In: Burgess R, editor. Protein purification: micro to macro. New York (NY): Alan R. Liss Inc; p. 271–278.
   Google Scholar
• Rodriguez-Valera F. 1993. Introduction to saline environments. In: Vreeland RH, Hochstein LI, editors. The Biology Halophilic Bacteria. Boca Raton (FL): CRC Press; p. 1–23.
   Google Scholar
• Rodriguez-Valera F, Juez G, Kushner DJ. 1982. Halocins: salt-dependent bacteriocins produced by extremely halophilic rods. Can J Microbiol. 28(1):151–154.
   Web of Science ®Google Scholar
• Roshan K, Tarafdar A, Saurav K, Ali S, Lone SA, Pattnaik S, et al. 2013. Isolation and screening of bioactive compound from actinomycetes isolated from salt pan of Marakanam district of the state Tamil Nadu, India. Elixir Int J:61:16826–16831.
   Google Scholar
• Rothschild LJ, Mancinelli RL. 2001. Life in extreme environments. Nature. 409(6823):1092–1101.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Saha M, Roy D, Jaisankar P, Das S, Gauri Roy L, Gachhui R, Sen T, Mukherjee J. 2008. Enhanced production of antimicrobial compounds by three salt-tolerant actinobacterial strains isolated from the Sundarbans in a niche-mimic bioreactor. Mar Biotechnol. 10(5):518–526.
   PubMed Web of Science ®Google Scholar
• Sawale A, Kadam TA, Karale MA, Kadam OA. 2014. Antimicrobial Activity of Secondary Metabolites from Halophilic Bacillus pumilus sp. Int J Curr Microbiol Applied Sci. 3:506–512.
   Google Scholar
• Schäberle TF, Goralski E, Neu E, Erol O, Hölzl G, Dörmann P, Bierbaum G, König GM. 2010. Marine myxobacteria as a source of antibiotics—comparison of physiology, polyketide-type genes and antibiotic production of three new isolates of Enhygromyxa salina. Mar Drugs. 8(9):2466–2479.,.
   PubMed Web of Science ®Google Scholar
• Schatz A, Bugle E, Waksman SA. 1944. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Proc Soc Exp Biol Med. 55(1):66–69.
   Google Scholar
• Scheffler RJ, Colmer S, Tynan H, Demain AL, Gullo VP. 2013. Antimicrobials, drug discovery, and genome mining. Appl Microbiol Biotechnol. 97(3):969–978.
   PubMed Web of Science ®Google Scholar
• Scherlach K, Hertweck C. 2006. Discovery of aspoquinolones A–D, prenylated quinoline-2-one alkaloids from Aspergillus nidulans, motivated by genome mining. Org Biomol Chem. 4(18):3517–3520.
   PubMed Web of Science ®Google Scholar
• Schulz D, Beese P, Ohlendorf B, Erhard A, Zinecker H, Dorador C, Imhoff JF. 2011. Abenquines A–D: aminoquinone derivatives produced by Streptomyces sp. strain DB634. J Antibiot. 64(12):763–768.
   PubMed Web of Science ®Google Scholar
• Sengupta S, Pramanik A, Ghosh A, Bhattacharyya M. 2015. Antimicrobial activities of actinomycetes isolated from unexplored regions of Sundarbans mangrove ecosystem. BMC Microbiol. 15:170. .
   PubMed Web of Science ®Google Scholar
• Sepcic K, Zalar P, Gunde-Cimerman N. 2010. Low water activity induces the production of bioactive metabolites in halophilic and halotolerant fungi. Mar Drugs. 9(1):43–58.
   PubMed Web of Science ®Google Scholar
• Shand R, Price O’Connor O. 1999. Halocins: protein antibiotics from hypersaline environments. In: Oren A, editor. Microbiology and biogeochemistry of hypersaline environments. Boca Raton (FL): CRC Press. [accessed 2017 Mar 20]. https://books.google.co.uk/books?hl=en&lr=&id=rBk1hHU1zx8C&oi=fnd&pg=PA295&dq=halocins:+protein+antibiotics+from+hypersaline+environments.+in+Microbiology+and+biogeochemistry+of+hypersaline+environments.&ots=SKvUZkjrCk&sig=fpTwNykfaSP343Ks3eZm-JWkQPM#v=on.
   Google Scholar
• Shand RF. 2006. 29 detection, quantification and purification of halocins: peptide antibiotics from haloarchaeal extremophiles. Methods Microbiol. 35:703–718.
   Web of Science ®Google Scholar
• Shand RF, Leyva KJ. 2007. Peptide and protein antibiotics from the domain Archaea: halocins and sulfolobicins. In: Riley MA, Chavan MA, editors. Bacteriocins. Berlin/Heidelberg, Germany: Springer; p. 93–109.
   Google Scholar
• Shand RF, Leyva KJ. 2008. Archaeal antimicrobials: an undiscovered country. In: Blum P, editor. Archaea: new models for prokaryotic biology. Norfolk: Caister Academic Press.
   Google Scholar
• Shand R, Price L, O’Connor E. 1998. Halocins: protein antibiotics from hypersaline environments. In: Oren A, editor. Microbiology and biogeochemistry of hypersaline environments. Boca Raton: CRC Press; p. 295–306.
   Google Scholar
• Sharma AK, Gohel S, Singh SP. 2012. Actinobase: database on molecular diversity, phylogeny and biocatalytic potential of salt tolerant alkaliphilic actinomycetes. Bioinformation. 8(11):535–538.
   PubMedGoogle Scholar
• Shiomi K, Iinuma H, Naganawa H, Hamada M, Hattori S, Nakamura H, Takeuchi T, Iitaka Y. 1990. New antibiotic produced by micromonospora globosa. J Antibiot. 43(8):1000–1005.
   PubMed Web of Science ®Google Scholar
• Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH. 2005. Marine natural products as anticancer drugs. Mol Cancer Ther. 4(2):333–342.
   PubMed Web of Science ®Google Scholar
• Simpkin VL, Renwick MJ, Kelly R, Mossialos E. 2017. Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps. J Antibiot. 70(12):1087–1096. .
   PubMed Web of Science ®Google Scholar
• Singh LS, Baruah I, Bora TC. 2006. Actinomycetes of Loktak habitat: isolation and screening for antimicrobial activities. Biotechnology. 5(2):217–221.
   Google Scholar
• Soppa J, Oesterhelt D. 1989. Halobacterium sp. GRB: a species to work with!? Can J Microbiol. 35(1):205–209.
   PubMed Web of Science ®Google Scholar
• Sorokin DY, Tourova TP, Lysenko AM, Muyzer G. 2006. Diversity of culturable halophilic sulfur-oxidizing bacteria in hypersaline habitats. Microbiology. 152(Pt 10):3013–3023.
   PubMed Web of Science ®Google Scholar
• Stewart EJ. 2012. Growing unculturable bacteria. J Bacteriol. 194(16):4151–4160.
   PubMed Web of Science ®Google Scholar
• Sun C, Li Y, Mei S, Lu Q, Zhou L, Xiang H. 2005. A single gene directs both production and immunity of halocin C8 in a haloarchaeal strain AS7092. Mol Microbiol. 57(2):537–549.
   PubMed Web of Science ®Google Scholar
• Sun Y, Tomura T, Sato J, Iizuka T, Fudou R, Ojika M. 2016. Isolation and biosynthetic analysis of haliamide, a new PKS-NRPS hybrid metabolite from the marine myxobacterium Haliangium ochraceum. Molecules. 21(1):59.
   PubMed Web of Science ®Google Scholar
• Suthindhiran K, Kannabiran K. 2009. Cytotoxic and antimicrobial potential of actinomycete species Saccharopolyspora salina VITSDK4 isolated from the Bay of Bengal Coast of India. American J of Infectious Diseases. 5(2):90–98.
   Google Scholar
• Swan BK, Ehrhardt CJ, Reifel KM, Moreno LI, Valentine DL. 2010. Archaeal and bacterial communities respond differently to environmental gradients in anoxic sediments of a California hypersaline lake, the Salton Sea. Appl Environ Microbiol. 76(3):757–768.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Hanada S, Manome A, Tsuchida T, Kurane R, Nakamura K, Kamagata Y. 2004. Catellibacterium nectariphilum gen. nov., sp. nov., which requires a diffusible compound from a strain related to the genus Sphingomonas for vigorous growth. Int J Syst Evol Microbiol. 54(Pt 3):955–959.
   PubMedGoogle Scholar
• Tang K, Zhang X-H. 2014. Quorum quenching agents: resources for antivirulence therapy. Mar Drugs. 12(6):3245–3282.
   PubMed Web of Science ®Google Scholar
• Teasdale ME, Donovan KA, Forschner-Dancause SR, Rowley DC. 2011. Gram-positive marine bacteria as a potential resource for the discovery of quorum sensing inhibitors. Mar Biotechnol. 13(4):722–732.
   PubMed Web of Science ®Google Scholar
• Teasdale ME, Liu J, Wallace J, Akhlaghi F, Rowley DC. 2009. Secondary metabolites produced by the marine bacterium Halobacillus salinus that inhibit quorum sensing-controlled phenotypes in gram-negative bacteria. Appl Environ Microbiol. 75(3):567–572.
   PubMed Web of Science ®Google Scholar
• Thaker MN, Wang W, Spanogiannopoulos P, Waglechner N, King AM, Medina R, Wright GD. 2013. Identifying producers of antibacterial compounds by screening for antibiotic resistance. Nat Biotechnol. 31(10):922–927.
   PubMed Web of Science ®Google Scholar
• Thumar JT, Dhulia K, Singh SP. 2010. Isolation and partial purification of an antimicrobial agent from halotolerant alkaliphilic Streptomyces aburaviensis strain Kut-8. World J Microbiol Biotechnol. 26(11):2081–2087.
   Web of Science ®Google Scholar
• Tian S, Yang Y, Liu K, Xiong Z, Xu L, Zhao L. 2014. Antimicrobial metabolites from a novel halophilic actinomycete Nocardiopsis terrae YIM 90022. Nat Prod Res. 28(5):344–346.
   PubMed Web of Science ®Google Scholar
• Tian S-Z, Pu X, Luo G, Zhao L-X, Xu L-H, Li W-J, Luo Y. 2013. Isolation and characterization of new p-Terphenyls with antifungal, antibacterial, and antioxidant activities from halophilic actinomycete Nocardiopsis gilva YIM 90087. J Agric Food Chem. 61(12):3006–3012.
   PubMed Web of Science ®Google Scholar
• Tommonaro G, Abbamondi GR, Iodice C, Tait K, De Rosa S. 2012. Diketopiperazines produced by the halophilic archaeon, Haloterrigena hispanica, activate AHL bioreporters. Microb Ecol. 63(3):490–495.
   PubMed Web of Science ®Google Scholar
• Torreblanca M, Meseguer I, Rodriguez-Valera F. 1989. Halocin H6, a bacteriocin from Haloferax gibbonsii. J Gen Microbiol. 135(10):2655–2661.
   Google Scholar
• Torreblanca M, Meseguer I, Ventosa A. 1994. Production of halocin is a practically universal feature of archaeal halophilic rods. Lett Appl Microbiol. 19(4):201–205.
   Web of Science ®Google Scholar
• Tresner HD, Hayes JA, Backus EJ. 1968. Differential tolerance of streptomycetes to sodium chloride as a taxonomic aid. Appl Microbiol. 16(8):1134–1136.
   PubMedGoogle Scholar
• Tulp M, Bohlin L. 2005. Rediscovery of known natural compounds: nuisance or goldmine? Bioorg Med Chem. 13(17):5274–5282.
   PubMed Web of Science ®Google Scholar
• Udwary DW, Zeigler L, Asolkar RN, Singan V, Lapidus A, Fenical W, Jensen PR, Moore BS. 2007. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. Proc Natl Acad Sci U S A. 104(25):10376–10381.
   PubMed Web of Science ®Google Scholar
• Vartoukian SR, Palmer RM, Wade WG. 2010. Cultivation of a synergistetes strain representing a previously uncultivated lineage. Environ Microbiol. 12(4):916–928.
   PubMed Web of Science ®Google Scholar
• Vasavada SH, Thumar JT, Singh SP. 2006. Secretion of a potent antibiotic by salt-tolerant and alkaliphilic actinomycete Streptomyces sannanensis strain RJT-1. Curr Sci. 91:1393–1397.
   Web of Science ®Google Scholar
• Velho-Pereira S, Furtado I. 2012. Antibacterial activity of halophilic bacterial bionts from marine invertebrates of Mandapam-India. Indian J Pharm Sci. 74(4):331–338.
   PubMed Web of Science ®Google Scholar
• Velmurugan S, Raman K, Thanga Viji V, Donio MBS, Adlin Jenifer J, Babu MM, Citarasu T. 2013. Screening and characterization of antimicrobial secondary metabolites from Halomonas salifodinae MPM-TC and its in vivo antiviral influence on Indian white shrimp Fenneropenaeus indicus against WSSV challenge. J King Saud Univ Sci. 25(3):181–190.
   Google Scholar
• Von Nussbaum F, Brands M, Hinzen B, Weigand S, Häbich D. 2006. Antibacterial natural products in medicinal chemistry – Exodus or revival? Angew Chem Int Ed Engl. 45(31):5072–5129.
   PubMed Web of Science ®Google Scholar
• Wang G, Dai S, Chen M, Wu H, Xie L, Luo X, Li X. 2010. Two diketopiperazine cyclo(PRO-PHE) isomers from marine bacteria Bacillus subtilis sp. 13-2. Chem Nat Compd. 46(4):583–585.
   Web of Science ®Google Scholar
• Wang S, Zheng Z, Zou H, Li N, Wu M. 2019. Characterization of the secondary metabolite biosynthetic gene clusters in archaea. Comput Biol Chem. 78:165–169.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhu T, Tao H, Lu Z, Fang Y, Gu Q, Zhu W. 2007. Two new cytotoxic quinone type compounds from the halotolerant fungus Aspergillus variecolor. J Antibiot. 60(10):603–607.
   PubMed Web of Science ®Google Scholar
• Watve MG, Tickoo R, Jog MM, Bhole BD. 2001. How many antibiotics are produced by the genus Streptomyces? Arch Microbiol. 176(5):386–390.
   PubMed Web of Science ®Google Scholar
• Weber T. 2014. In silico tools for the analysis of antibiotic biosynthetic pathways. Int J Med Microbiol. 304(3–4):230–235.
   PubMed Web of Science ®Google Scholar
• Wegmann K, Ben-Amotz A, Avron M. 1980. Effect of temperature on glycerol retention in the halotolerant algae dunaliella and asteromonas. Plant Physiol. 66(6):1196–1197.
   PubMed Web of Science ®Google Scholar
• Weiss C, Figueras E, Borbely AN, Sewald N. 2017. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting. J Pept Sci. 23(7–8):514–531.
   PubMed Web of Science ®Google Scholar
• Wilson ZE, Brimble MA. 2009. Molecules derived from the extremes of life. Nat Prod Rep. 26(1):44–71.
   PubMed Web of Science ®Google Scholar
• Woese CR, Fox GE. 1977. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci U S A. 74(11):5088–5090.
   PubMed Web of Science ®Google Scholar
• Xiang W, Guo J, Feng W, Huang M, Chen H, Zhao J, Zhang J, Yang Z, Sun Q. 2008. Community of extremely halophilic bacteria in historic dagong brine well in southwestern China. World J Microbiol Biotechnol. 24(10):2297–2305.
   Web of Science ®Google Scholar
• Yoshida M, Matsubara K, Kudo T, Horikoshi K. 1991. Actinopolyspora mortivallis sp. nov., a moderately halophilic actinomycete. Int J Syst Bacteriol. 41(1):15–20.
   Google Scholar
• Zalar P, De Hoog GS, Schroers H-J, Frank JM, Gunde-Cimerman N. 2005. Taxonomy and phylogeny of the xerophilic genus Wallemia (Wallemiomycetes and Wallemiales, cl. et ord. nov.). Antonie Van Leeuwenhoek. 87(4):311–328.
   PubMed Web of Science ®Google Scholar
• Zaremba-Niedzwiedzka K, Caceres EF, Saw JH, Bäckström D, Juzokaite L, Vancaester E, Seitz KW, Anantharaman K, Starnawski P, Kjeldsen KU, et al. 2017. Asgard archaea illuminate the origin of eukaryotic cellular complexity. Nature. 541(7637):353–358.
   PubMed Web of Science ®Google Scholar
• Zhao L-X, Huang S-X, Tang S-K, Jiang C-L, Duan Y, Beutler JA, Henrich CJ, McMahon JB, Schmid T, Blees JS, et al. 2011. Actinopolysporins A–C and tubercidin as a Pdcd4 stabilizer from the halophilic actinomycete Actinopolyspora erythraea YIM 90600. J Nat Prod. 74(9):1990–1995. [doi].
   PubMed Web of Science ®Google Scholar
• Zheng Y, Saitou A, Wang C-M, Toyoda A, Minakuchi Y, Sekiguchi Y, Ueda K, Takano H, Sakai Y, Abe K, et al. 2019. Genome features and secondary metabolites biosynthetic potential of the class Ktedonobacteria. Front Microbiol. 10:893.
   PubMed Web of Science ®Google Scholar